Starling Oncology, Inc. STLN
$6.94
$0.314.60%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 35.66% | -23.80% | -32.42% | -41.65% | -34.66% |
| Total Receivables | 19.26% | 19.70% | 21.85% | 9.33% | 2.88% |
| Inventory | 26.76% | 97.35% | 68.09% | 86.84% | 39.43% |
| Prepaid Expenses | -57.68% | -44.33% | -25.86% | -11.91% | -33.15% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 23.09% | 9.40% | 0.29% | -5.44% | -9.82% |
|
|
|||||
| Total Current Assets | 23.09% | 9.40% | 0.29% | -5.44% | -9.82% |
| Net Property, Plant & Equipment | -8.55% | -5.97% | -12.24% | -13.66% | -11.43% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -23.01% | -26.62% | -25.62% | -24.71% | -23.89% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.12% | 4.91% | 2.89% | -0.34% | 0.69% |
| Total Assets | 11.54% | 2.58% | -4.67% | -8.69% | -11.03% |
|
|
|||||
| Total Accounts Payable | 72.56% | 62.68% | 77.47% | 45.02% | 121.80% |
| Total Accrued Expenses | 137.41% | 104.43% | 23.90% | 27.25% | 38.03% |
| Short-term Debt | -14.01% | -- | 3.12% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.91% | 8.58% | 5.80% | 6.51% | 6.51% |
| Total Finance Division Other Current Liabilities | -52.78% | -55.79% | -24.76% | 72.14% | 113.10% |
| Total Other Current Liabilities | -52.78% | -55.79% | -24.76% | 72.14% | 113.10% |
| Total Current Liabilities | 46.56% | 33.27% | 35.90% | 40.26% | 84.54% |
|
|
|||||
| Total Current Liabilities | 46.56% | 33.27% | 35.90% | 40.26% | 84.54% |
| Long-Term Debt | 6.46% | 6.38% | -16.89% | -16.76% | -16.59% |
| Short-term Debt | -14.01% | -- | 3.12% | -- | -- |
| Capital Leases | -18.05% | -12.88% | -17.50% | -18.35% | -13.78% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 41.12% | 99.92% | 2,199.64% | 1,974.52% | 965.52% |
| Total Liabilities | 20.36% | 16.10% | 6.65% | 7.45% | 12.23% |
|
|
|||||
| Common Stock & APIC | 8.50% | 9.37% | 19.17% | 17.99% | 13.08% |
| Retained Earnings | -14.67% | -18.89% | -28.75% | -33.54% | -36.30% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -177.28% | -421.27% | -538.01% | -179.28% | -130.76% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -177.28% | -421.27% | -538.01% | -179.28% | -130.76% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -177.28% | -421.27% | -538.01% | -179.28% | -130.76% |
|
|
|||||